TCT recap: A Q&A with Gregg Stone

Gregg W. Stone, MD, co-director of the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco, discussed the history of the 25-year-old event and its clinical trials with Cardiovascular Business in a two-part Q&A.

Part one, “From early tools to tablets,” is here. Part two, “Moving from anecdotal to evidence-based medicine,” is here.